Immix Biopharma target price raised to $30 by Needham
IMMX•Needham raised its target price for Immix Biopharma to $30.
Related News
Owens Corning: Jefferies cuts target price to $165 from $180
OC•
Saudi exports led the recovery, rising above their 2025 average, while Iran shipped no crude by sea in September
USO•
Alnylam Pharmaceuticals: JPMorgan cuts target price to $369 from $375
ALNY•
Carnival Corp: JPMorgan raises target price to $41 from $39
CCL•
Colombia central bank expected to hold rate despite inflationary pressures
TLT•